Description

6-(7-Theophylline)-3(2H)-Pyridazinone is a specialized heterocyclic organic compound that serves as a key synthetic intermediate in advanced pharmaceutical research and development. Its unique molecular structure, combining theophylline and pyridazinone moieties, makes it a valuable building block for creating novel bioactive molecules. This high-purity intermediate is primarily utilized by research institutions and pharmaceutical companies engaged in the discovery of new therapeutic agents, particularly in the fields of central nervous system (CNS) and cardiovascular drug development.

Application

• Pharmaceutical Intermediate: A critical precursor in the synthesis of novel drug candidates targeting adenosine receptors.
• Medicinal Chemistry Research: Used as a scaffold for structure-activity relationship (SAR) studies to develop new chemical entities with potential therapeutic effects.
• Biochemical Tool Compound: Employed in in vitro assays to study enzyme inhibition and receptor binding mechanisms related to theophylline's pharmacological pathways.
• Academic Research: Serves as a reference standard and starting material in university laboratories for heterocyclic chemistry and organic synthesis projects.
• Contract Research Organizations (CROs): Utilized in custom synthesis and process development for client-specific drug discovery programs.

Basic Information

Product Name	6-(7-Theophylline)-3(2H)-Pyridazinone
CAS No.	139026-57-6
Molecular Formula	C₁₁H₁₀N₆O₂
Molecular Weight	258.24 g/mol
Synonyms	6-(7-Theophyllinyl)-3(2H)-pyridazinone; 6-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-3(2H)-pyridazinone; 7-(6-Oxo-1,6-dihydropyridazin-3-yl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione; Theophylline-pyridazinone derivative; 6-(1,3-Dimethylxanthin-7-yl)-3(2H)-pyridazinone
EINECS	Contact for details

Quality Control

Our 6-(7-Theophylline)-3(2H)-Pyridazinone is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity suitable for research applications. Each lot undergoes comprehensive analytical testing, including HPLC for purity and spectroscopic identification (NMR, IR, MS). A detailed Certificate of Analysis (COA) is provided with every shipment, documenting all critical quality attributes. We adhere to cGMP principles for the production of pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (15-25°C). Keep the container tightly sealed in a dry environment to prevent moisture absorption. Handle and store in accordance with good laboratory practices.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.